Patient info Open main menu

Depo-provera 150 mg / ml vial – Summary of Product Characteristics (SmPC) for healthcare professionals

Medicine status: Prescription only (POM) Details

Medicine strength:
150 mg / ml
Other strengths and forms:
Contains active substance:
ATC code:
Similar medicines:

Sources: Original (products.mhra.gov.uk)

Summary of Product Characteristics (SmPC) - Depo-provera 150 mg / ml vial

4. CLINICAL PARTICULARS

4.1. Therapeutic indications

Not applicable

4.2. Posology and method of administration

Not applicable

4.3. Contrain­dications

Not applicable

4.4. Special warnings and precautions for use

Not applicable

4.5. Interactions with other medicinal products and other forms of interaction

Not applicable

4.6. Pregnancy and lactation

Not applicable

4.7. Effects on ability to drive and use machines

Not applicable

4.8. Undesirable effects

Not applicable

4.9. Overdose

Not applicable

5. PHARMACOLOGICAL PROPERTIES

5.1. Pharmaco­dynamic properties

Not applicable

5.2. Pharmaco­kinetic properties

Not applicable

5.3. Preclinical safety data

Not applicable

Sources: Original (products.mhra.gov.uk)

Facts about Depo-provera 150 mg / ml vial

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Medroxyprogesterone
Strength 150 mg / ml
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)
  1. G Genito urinary system and sex hormones
    1. G03 Sex hormones and modulators of the genital system
      1. G03A Hormonal contraceptives for systemic use
        1. G03AC Progestogen systemic hormonal contraceptives
          1. G03AC06 medroxyprogesterone

Sources: the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.